Sattva S. Neelapu, MD¹, Michael Dickinson, MBBS², Javier Munoz, MD, MS, MBA, FACP³, Matthew L. Ulrickson, MD³, Catherine Thieblemont, MD, PhD⁴, Olalekan O. Oluwole, MBBS, MPH⁵, Alex F. Herrera, MD⁶, Chaitra S. Ujjani, MD⁷, Yi Lin⁸, Peter A. Riedell, MD⁹, Natasha Kekre, MD, FRCPC¹⁰, Sven de Vos¹¹, Christine Lui, MS^12*, Francesca Milletti, PhD^12*, Jinghui Dong, PhD^12*, Hairong Xu, MD, PhD^12* and Julio C. Chavez, MD¹³

¹Department of Lymphoma and Myeloma, M.D. Anderson Cancer Center, Houston, TX
²Department of Clinical Haematology, Peter MacCallum Cancer Centre, Royal Melbourne Hospital and and the University of Melbourne, Melbourne, VIC, Australia
³Banner MD Anderson Cancer Center, Gilbert, AZ
⁴Department of Hemato-Oncology, Saint Louis Hospital, Paris, France
⁵Vanderbilt-Ingram Cancer Center, Nashville, TN
⁶City of Hope National Medical Center, Duarte, CA
⁷Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center, Seattle, WA
⁸Mayo Clinic, Rochester, MN
⁹Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
¹⁰The Ottawa Hospital, Ottawa, ON, Canada
¹¹David Geffen School of Medicine at UCLA, Santa Monica, CA
¹²Kite, a Gilead Company, Santa Monica, CA
¹³Moffitt Cancer Center, Tampa, FL

Ian W. Flinn, MD, PhD¹, Ulrich Jaeger², Nirav N. Shah, MD³, Didier Blaise⁴, Javier Briones, MD, PhD^5*, Leyla Shune, MD⁶, Nicolas Boissel, MD, PhD⁷, Attilio Bondanza, MD^8*, Darlene Lu, PhD^9*, Xu Zhu, PhD^9*, Boris Engels, PhD^9*, Jennifer L Brogdon, PhD^9*, Jennifer Mataraza, PhD^9*, Jaclyn Davis, MD¹⁰, Anne Laure Marchal^8*, Luisa Mariconti, MSc^8*, Michele Moschetta, MD, PhD^8*, Laure Moutouh-de Parseval, MD^8*, Pere Barba, MD, PhD^11* and Michael Dickinson, MBBS¹²

¹Sarah Cannon Research Institute-Tennessee Oncology, Nashville, TN
²Clinical Division of Hematology and Hemostaseology, Department of Medicine I, Vienna General Hospital – Medical University of Vienna, Vienna, Austria
³Medical College of Wisconsin, Milwaukee, WI
⁴Département d'hématologie, Programme de transplantation et de thérapie Cellulaire, Centre de Recherche en Cancérologie de Marseille, Aix-Marseille University, Institut Paoli Calmettes, Marseille, France
⁵Department of Hematology, Hospital Santa Creu i Sant Pau, Barcelona, Spain
⁶University of Kansas Medical Center, Kansas City, KS
⁷St-Louis Hospital, APHP, Adolescents and Young Adults Hematology Department, Paris, France
⁸Novartis Institutes for BioMedical Research, Basel, Switzerland
⁹Novartis Institutes for BioMedical Research, Cambridge, MA
¹⁰Novartis Institutes for BioMedical Research, East Hanover, NJ
¹¹Hematology Department, Hospital Universitari Vall d'Hebrón, Universitat Autònoma de Barcelona, Barcelona, Spain
¹²Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia

Matthew J. Frank, MD, PhD^1,2*, John H. Baird, MD^1,2, Shabnum Patel, PhD^3*, Juliana Craig, BA^1,2*, Jay Y. Spiegel, MD, FRCPC^1,2, Zachary Ehlinger, MS^3*, Harshini Chinnasamy, MS^2*, Sheren F. Younes, MD, PhD^4*, Jean S. Oak, MD, PhD^5*, Yasodha Natkunam, MD, PhD⁴, Warren D. Reynolds, BS^3*, Maria Iglesias, BS^1,2*, Emma Crawford, BS^2,6*, Hrishikesh K. Srinagesh, MD¹, Emily L. Egeler, PhD^2*, Sally Arai, MD, MS¹, Laura J. Johnston, MD¹, Robert Lowsky, MD¹, Robert S. Negrin, MD¹, Andrew R. Rezvani, MD¹, Parveen Shiraz, MD⁷, Surbhi Sidana, MD^1,2, Wen-Kai Weng, MD, PhD¹, Liora M. Schultz, MD⁸, Sneha Ramakrishna, MD⁸, Kara L. Davis, DO⁹, Bita Sahaf, PhD^2*, Steven A. Feldman, PhD^2*, Crystal L. Mackall, MD^10,11, David B. Miklos, MD, PhD^1,2 and Lori Muffly, MD^2,12

¹Division of BMT and Cellular Therapy, Stanford University School of Medicine, Stanford, CA
²Center for Cancer Cell Therapy, Stanford University School of Medicine, Stanford, CA
³Center for Cancer Cell Therapy, Stanford University, Stanford, CA
⁴Department of Pathology, Stanford University School of Medicine, Stanford, CA
⁵Department of Pathology, Stanford University Medical Center, Stanford, CA
⁶Division of BMT and Cellular Therapy, Stanford University Hospital, Stanford, CA
⁷Division of BMT and Cellular Therapy, Stanford University, Stanford, CA
⁸Department of Pediatrics, Division of Hematology and Oncology, Stanford University School of Medicine, Palo Alto, CA
⁹Department of Pediatrics, Division of Hematology, Oncology and Stem Cell Transplant, Stanford University School of Medicine, Stanford, CA
¹⁰Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA
¹¹Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA
¹²Division of BMT and Cellular Therapy, Associate Professor of Medicine Bone & Marrow Transplantation Stanford University Medical Center, Stanford, CA

Natalie S Grover, MD¹, Anastasia Ivanova, PhD^1*, Dominic T. Moore, MPH, MS^1*, Catherine Joyce Arago Cheng, BS^1*, Caroline Babinec, BA^1*, John West, PhD^1*, Tammy Cavallo, BS^1*, J. Kaitlin Morrison, PhD^1*, Faith Brianne Buchanan, PA^1*, Edith Bowers, MD, PhD^2*, Christopher Dittus, DO¹, Anne W. Beaven, MD¹, Gianpietro Dotti, MD^1*, Jonathan S. Serody, MD¹ and Barbara Savoldo, MD, PhD^1*

¹Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
²Department of Dermatology, University of North Carolina, Chapel Hill, NC

Charles Herbaux, MD¹, Caroline Bret, PhD, PharmD^2*, Roberta Di Blasi, MD, PhD^3*, Emmanuel Bachy, MD, PhD^4*, David Beauvais, MD^5*, Elodie Gat^6*, Thomas Gastinne, MD^7*, Florence Broussais^8*, Guillaume Cartron, MD, PhD^9*, Alexis Cuffel^10*, Loic Ysebaert, MD, PhD^11*, Mikael Roussel, MD, PhD^12*, Krimo Bouabdallah^13*, Julien Guy, MD^14*, Arnaud Campidelli^15*, François Van Laethem^16*, Rene-Olivier Casasnovas, MD^17*, Remy Dulery^18*, Franck Morschhauser, MD, PhD^19*, Sophie Caillat-Zucman, MD, PhD^20*, Roch Houot^21* and Steven Le Gouill²²

¹Hematology Department, Montpellier University Hospital, Montpellier, France, Montpellier, France
²University of Montpellier, UFR Medecine, Montpellier, France
³Department of Hematology, Assistance Publique Hôpitaux de Paris - Hopital Saint-Louis, University of Paris, Paris, France
⁴Department of Hematology, Lyon Sud Hospital, Lyon, France
⁵Hématologie clinique, CHU de Lille, Lille, France
⁶Institut Carnot CALYM, PIERRE-BENITE, FRA
⁷Clinical Hematology, University Hospital of Nantes,, Nantes Cedex 1, France
⁸LYSARC, Lyon, France
⁹Département d'Hématologie clinique, CHU de Montpellier, Montpellier, France
¹⁰APHP, hôpital Saint-Louis; Immunologie, Paris, France
¹¹Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France
¹²CHU Rennes, Rennes, France
¹³Department of Hematology and Cell Therapy, University Hospital, Bordeaux, France
¹⁴Laboratoire d'Hématologie, Centre Hospitalier Universitaire de Dijon, DIJON, France
¹⁵CHU, Nancy, France
¹⁶CHU, Montpellier, France
¹⁷Department of Hematology, CHU Dijon, Dijon, France
¹⁸Saint-Antoine Research Center, Inserm UMR938, Sorbonne Université, Paris, France
¹⁹Hematology Department, Lille University Hospital, Lille, France
²⁰Laboratory of Immunology, Saint Louis Hospital, APHP, Paris, France
²¹CHU, Rennes, FRA
²²Service d’hématologie clinique du CHU de Nantes, INSERM CRCINA Nantes-Angers, NeXT Université de Nantes, Nantes, France

Yucai Wang, MD, PhD¹, Preetesh Jain, MBBS, MD, DM, PhD², Frederick L. Locke, MD³, Javier Munoz, MD, MS, MBA, FACP⁴, Matthew J. Maurer, MS, DMSc⁵, Amer Beitinjaneh, MD, MPH, MSc^6*, Matthew J. Frank, MD, PhD⁷, Saurabh Dahiya, MD⁸, Joseph P. McGuirk, DO⁹, Miriam T. Jacobs, MD¹⁰, Andre H. Goy, MD^11*, Julie M. Vose, MD, MBA¹², Brian T. Hill, MD¹³, Olalekan O. Oluwole, MBBS, MPH¹⁴, Abhinav Deol¹⁵, Bijal D. Shah, MD¹⁶, Jonas Paludo, MD¹, Trent Wang, DO, MPH⁶, Lazaros J. Lekakis, MD^6*, David B. Miklos, MD, PhD⁷, Aaron P. Rapoport, MD⁸, Armin Ghobadi, MD¹⁰, Sattva S. Neelapu, MD², Yi Lin¹, Michael Wang, MD² and Michael D. Jain, MD, PhD³

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
⁴Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ
⁵Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
⁶Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL
⁷Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University Hospital, Stanford, CA
⁸University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
⁹Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Cancer Center, Westwoon, KS
¹⁰Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
¹¹Division of Lymphoma, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
¹²Division of Hematology & Oncology, Department of Internal Medicine, University of Nebraska Medical Center- Fred and Pamela Buffett Cancer Center, Omaha, NE
¹³Department of Hematology and Medical Oncology, Cleveland Clinic Foundation, Cleveland, OH
¹⁴Vanderbilt University Medical Center, Nashville, TN
¹⁵Karmanos Cancer Institute, Wayne State University, Detroit, MI
¹⁶Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL